dc.contributor.author | Conseil exécutif, 63 | |
dc.coverage.spatial | Genève | EN |
dc.date.accessioned | 2015-03-29T16:16:56Z | |
dc.date.available | 2015-03-29T16:16:56Z | |
dc.date.issued | 1978 | |
dc.identifier.govdoc | EB63/19 | |
dc.identifier.uri | https://iris.who.int/handle/10665/159718 | |
dc.description | Point 19 de l'ordre du jour provisoire. | EN |
dc.language.iso | fr | EN |
dc.publisher | Organisation Mondiale de la Santé | EN |
dc.subject.mesh | Pharmaceutical Preparations | EN |
dc.subject.mesh | Drugs, Essential | EN |
dc.subject.mesh | Health Surveys | EN |
dc.subject.mesh | Drug Industry | EN |
dc.subject.mesh | Drug Delivery Systems | EN |
dc.subject.mesh | Drug and Narcotic Control | EN |
dc.subject.mesh | Drug Evaluation | EN |
dc.subject.mesh | National Health Programs | EN |
dc.subject.mesh | Primary Health Care | EN |
dc.subject.mesh | Developing Countries | EN |
dc.title | Programme d’action concernant les médicaments essentiels | EN |
dc.type | Governing body documents | EN |
dc.subject.meshqualifier | supply and distribution | EN |
dc.subject.meshqualifier | organization and administration | EN |